# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Lake Street analyst Ben Klieve maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price target from $...
Canaccord Genuity analyst Austin Moeller downgrades Bioceres Crop Solutions (NASDAQ:BIOX) from Buy to Hold and lowers the pr...
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimat...